Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

$24.99

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

UnitedHealth Group Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Medical costs payable
Accounts payable and accrued liabilities
Short-term borrowings and current maturities of long-term debt
Unearned revenues
Other current liabilities
Current liabilities
Long-term debt, less current maturities
Deferred income taxes
Other liabilities
Noncurrent liabilities
Total liabilities
Redeemable noncontrolling interests
Preferred stock, $0.001 par value; no shares issued or outstanding
Common stock, $0.01 par value
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Shareholders’ equity attributable to UnitedHealth Group
Nonredeemable noncontrolling interests
Total equity
Total liabilities, redeemable noncontrolling interests and equity

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The composition of liabilities and stockholders’ equity exhibited several notable trends between 2021 and 2025. Overall, total liabilities increased as a percentage of the total, while total equity decreased proportionally. Within these broad categories, shifts in specific accounts reveal more granular changes in the company’s financial structure.

Current Liabilities
Current liabilities as a percentage of the total initially decreased from 36.89% in 2021 to 34.79% in 2024, before increasing to 37.11% in 2025. This fluctuation suggests potential changes in short-term financing strategies or working capital management. Medical costs payable and accounts payable and accrued liabilities, the largest components of current liabilities, remained relatively stable, fluctuating between 11% and 13% each, but contributed to the overall trend. Short-term borrowings and current maturities of long-term debt decreased initially, then increased in 2025, indicating a possible shift in reliance on short-term debt.
Noncurrent Liabilities
Noncurrent liabilities demonstrated a general upward trend, increasing from 27.07% in 2021 to 30.04% in 2025. Long-term debt, less current maturities, was the primary driver of this increase, rising from 19.97% to 23.36% over the period. Deferred income taxes decreased significantly, particularly between 2024 and 2025, potentially reflecting changes in tax planning or deferred tax asset realization.
Total Liabilities
Total liabilities increased steadily as a percentage of the total, moving from 63.96% in 2021 to 67.15% in 2025. This indicates a growing reliance on debt financing relative to equity. Redeemable noncontrolling interests experienced volatility, peaking at 1.99% in 2022 before declining to 0.52% in 2025, suggesting changes in ownership structures or consolidation activities.
Stockholders’ Equity
Total equity decreased from 35.36% in 2021 to 32.33% in 2025. Retained earnings, the largest component of equity, consistently decreased over the period, from 36.35% to 30.88%, likely due to dividend payouts or share repurchases. Accumulated other comprehensive loss also decreased, becoming less negative, which partially offset the decline in retained earnings. The appearance of additional paid-in capital in 2025, at 0.18%, suggests recent equity issuance or stock-based compensation activity.

In summary, the balance sheet composition shifted towards greater reliance on liabilities and away from equity over the five-year period. This trend was driven by increases in long-term debt and a decrease in retained earnings, alongside fluctuations in other liability and equity accounts. These changes warrant further investigation to understand the underlying business decisions and their potential impact on the company’s financial risk profile.